Biblio
Export 335 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is I [Clear All Filters]
“Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people.”, J Alzheimers Dis, p. 13872877251319535, 2025.
, “White matter lesions rather than amyloid-β burden are associated with cognitive decline in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251316516, 2025.
, “White matter lesions rather than amyloid-β burden are associated with cognitive decline in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251316516, 2025.
, “African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181.”, J Alzheimers Dis, vol. 98, no. 1, pp. 221-229, 2024.
, “On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. 1, pp. 293-308, 2024.
, “On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. 1, pp. 293-308, 2024.
, “Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice.”, J Alzheimers Dis, vol. 100, no. s1, pp. S341-S362, 2024.
, “Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function.”, J Alzheimers Dis, vol. 97, no. 2, pp. 953-961, 2024.
, “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
, “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
, “There are dementia patients in Gaza too.”, J Alzheimers Dis, vol. 102, no. 2, pp. 317-320, 2024.
, “Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 2, pp. 623-637., 2024.
, “Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1037-1049, 2023.
, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
, “Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.”, J Alzheimers Dis, vol. 96, no. 1, pp. 369-380, 2023.
, “Emotional Dysregulation in Mild Behavioral Impairment Is Associated with Reduced Cortical Thickness in the Right Supramarginal Gyrus.”, J Alzheimers Dis, vol. 93, no. 2, pp. 521-532, 2023.
, “Exposure to World Trade Center Dust Exacerbates Cognitive Impairment and Evokes a Central and Peripheral Pro-Inflammatory Transcriptional Profile in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 2, pp. 779-794, 2023.
, “Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 92, no. 1, pp. 153-169, 2023.
, “Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ 40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 1, pp. 333-348, 2023.
, “Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ 40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 1, pp. 333-348, 2023.
, “Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ 40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 1, pp. 333-348, 2023.
, “Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
, “Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”, J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
,